Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Antiandrogen therapy helps treat genetic hair loss.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Possible link between COVID-19 and hair loss; more research needed.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Hair loss from genetics and hormones can be treated with drugs or surgery.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Hormones significantly affect hair growth and loss, with potential for new treatments.